Parkinson's disease (PD) and dementia with Lewy bodies (DLB) have clinical features in common and are both characterized neuropathologically by the presence of Lewy bodies (LBs). We conducted a clinicopathological correlation pilot study to better understand whether PD and DLB represent two distinct nosological entities or rather exist along the spectrum of a single LB disease. A neuropathologist blinded to clinical diagnoses evaluated brains with largely pure LB pathology to determine LB distribution and frequency. Research clinicians blinded to LB distribution and frequency determined consensus clinical diagnoses. Clinical features separated cases into two groups, one having features most compatible with PD and the other with DLB. The groups were distinguishable mainly by the time course of clinical symptoms. Although the presence of neocortical LBs was more common in the group of patients with clinical features of DLB, neocortical LBs were also present in 1 member of the PD group and even in the clinically normal control subject. Thus, there appear to be two clinical syndromes, distinguished mainly by the time course of symptoms. The mechanisms responsible for the different clinical presentations are not known, and the issue of whether PD and DLB represent two distinct diseases remains unsettled. © 2002 Movement Disorder Society
- 1, , , et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113–1124.
- 2, , . Report of the second dementia with Lewy body international workshop. Neurology 1999; 53: 902–905.
- 3, . Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239–259.
- 4, , , , , . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939–944.
- 5, , , , , , , , , . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991; 41: 479–486.
- 6 The National Institute on Aging and Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S1–S2.
- 7, , , , . Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 1998; 95: 576–582.
- 8, , , . Neocortical Lewy body counts correlate with dementia in he Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996; 55: 44–52.
- 9, , , , , . Clinical and quantitative pathological correlates of dementia with Lewy bodies. Neurology 1999; 53: 1284–1291.
- 10, , , . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181–184.
- 11, , , et al. Lewy body, neurofibrillary tangle and senile plaque pathology in Parkinson's disease patients with and without dementia. Neurology 1999; 52: A476.